Use of inhibitors of bruton's tyrosine kinase (BTK)

  • US 9,801,881 B2
  • Filed: 11/26/2013
  • Issued: 10/31/2017
  • Est. Priority Date: 06/03/2010
  • Status: Active Grant
First Claim
Patent Images

1. A method for treating chronic lymphocytic leukemia in an individual who has failed at least one prior therapy for chronic lymphocytic leukemia comprising administering to the individual once per day about 420 mg of an oral dose of an inhibitor of Bruton'"'"'s tyrosine kinase (Btk) having the structure:

View all claims

    Thank you for your feedback